This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Four critical components in which the right specialtypharmacy partner can bring rare and gene therapy manufacturers the scale, expertise and capabilities needed to drive enhanced patient access.
Informa Connect's Hub and SpecialtyPharmacy Models West. September 14-15, 2022 Sheraton San Diego Hotel & Marina | San Diego, CA www.informaconnect.com/hub-specialty-pharmacy-west. Delivered as a Hybrid Event. Drug Channels readers will save 10% off the current registration rate when they use code 22DC10 *.
Informa Connect’s Hub and SpecialtyPharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and SpecialtyPharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof.
Today’s guest post comes from Megan Marchal, Director of SpecialtyPharmacy Strategy at CoverMyMeds. Megan discusses the access and affordability challenges faced by specialtytherapy patients. Click here to sign up for CoverMyMeds’ Asembia SpecialtyPharmacy Summit recaps. Read on for Megan’s insights.
Edward discusses how a technology-first approach automates manual processes for therapy initiation. He argues that such an approach can increase patient adherence, speed access to therapy, and improve the healthcare providers’ workflow. Read on for Edward’s insights.
She describes how human care plus an innovative, technology-driven patient support solution can help patients start therapy and get on the road to recovery. To learn more about CoverMyMeds’ specialtytherapy solutions , visit Booth 1519 at Asembia's SpecialtyPharmacy Summit in Las Vegas, April 30-May 4, 2023.
Learn more about AssistRx’s specialtytherapy initiation and patient support services at Asembia's SpecialtyPharmacy Summit on May 2-5, 2022. Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Click here to schedule your meeting.
Stacey discusses digital hubs and the affordability advantages they offer both patients on specialtytherapies and their health care providers. To learn more, click here to schedule a meeting with AssistRx at Asembia’s SpecialtyPharmacy Summit on April 30 to May 4, 2023.
He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. To learn more about CoAssist and AssistRx specialtytherapy initiation and patient support services, click here to schedule a meeting with AssistRx at the Asembia SpecialtyPharmacy Summit on May 2-5, 2022.
View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.
Last week, Paula and I had the pleasure of attending Asembia’s 2023 SpecialtyPharmacy Summit at the wonderful Wynn Las Vegas. I offer reflections on my keynote session with Seema Verma, share my experiences during the featured session, and highlight some crucial specialty industry trends.
Ela discusses the important role independent specialtypharmacies play in educating payers, supporting patients, and ultimately getting potentially life-saving therapies into the hands of patients. Today’s guest post comes from Ela Lourido, Vice President of Business Development at Biologics by Mckesson.
Stacey discusses how a patient support vendor can help specialtypharmacy patients attain prior authorizations and access critical therapies. Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx.
This important event convenes key stakeholders including manufacturers, specialtypharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph.,
My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialtypharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman.
In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialtypharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation.
Access USA will unite PAP – Patient Assistance & Access Programs, Hub and SpecialtyPharmacy Models East and the Rare Disease Summit three influential access conferences under one roof for one week of collaborative discussions and opportunities to expand your network and establish powerful partnerships. What is Access USA?
As pressure to optimize clinical research worldwide continues to mount, these NASA-like centers provide centralized accessibility, monitoring, and control over organizational processes, and coordinate the day-to-day activities of the clinical research system.
We commenced launch activities for the Remunity Pump for Remodulin, including shipping training devices to specialtypharmacies and certain health care practitioners, and entering into agreements with specialtypharmacies to purchase Remunity Pumps and accessories and to pre-fill the Remunity cartridges exclusively with Remodulin.
Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Many Progeria patients have received continuous Zokinvy therapy for more than 10 years. PALO ALTO, Calif., 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content